We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

$11M Study to Jumpstart Radiation Exposure Drug Development

News   Jan 16, 2019 | Original story from the University of Nebraska

 
$11M Study to Jumpstart Radiation Exposure Drug Development

Researchers Becky Deegan and Kenneth Bayles of the University of Nebraska Medical Center and David Berkowitz of the University of Nebraska chemistry department are jumpstarting the development of drug therapies to protect military service members from the effects of radiation exposure. The same therapies could be used to protect cancer patients receiving radiation treatments. Photo taken in the Department of Radiation Oncology at the Fred & Pamela Buffett Cancer Center in Omaha, Nebraska. Credit: Craig Chandler, University of Nebraska-Lincoln

 
 
 

RELATED ARTICLES

The Power of Genetic Testing – Picking Out the Best Drugs for Children With Cancer

News

A new study has shown the power of genetic testing to pick out the best drugs for children with cancer to extend and improve their lives – signalling a new era of precision medicine for young patients.

READ MORE

A Potential Drug Target for Diabetic Retinopathy

News

Approximately one in three diabetic patients develops diabetic retinopathy (DR), which can cause visual impairment and eventual blindness. Now researchers have discovered that high glucose increases the levels of enzymatic precursor, called lysyl oxidase propeptide (LOX-PP), that promotes cell death which could be a potential target for treating DR.

READ MORE

Team Discover Protein That Hampers Bone Healing

News

Scientists have discovered that a certain protein, which is more prevalent in older people, interferes with bone healing.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE